Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
OBJECTIVE
Cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) are widely used biomarkers for tobacco-derived nicotine and the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), respectively. The discrepancy between cotinine levels in relation to disease risk comparing active versus passive smoking suggests a nonlinear tobacco smoke dose-response and/or that cotinine is not providing an accurate measure of exposure to the toxic constituents of secondhand tobacco smoke.


METHODS
Cotinine and NNAL were measured in the urine of 373 active smokers and 228 passive smokers.


RESULTS
Average cotinine levels were 1,155 (interquartile range, 703-2,715) for active smokers and 1.82 (0.45-7.33) ng/mg creatinine for passive smokers. Average NNAL levels were 183 (103-393) and 5.19 (2.04-11.6) pg/mg creatinine, respectively. NNAL/cotinine ratio in urine was significantly higher for passive smokers when compared with active smokers (2.85 × 10(3) versus 0.16 × 10(3), P < 0.0001).


CONCLUSIONS
Passive smoking is associated with a much higher ratio of NNAL/cotinine in the urine compared with active smoking.


CONCLUSIONS
Cotinine measurement leads to an underestimation of exposure to the carcinogen NNK from secondhand smoke when compared with active smoking.
Benowitz
Neal
N
Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-1220, USA. NBenowitz@MedSFGH.ucsf.edu
Goniewicz
Maciej Lukasz
ML
Eisner
Mark D
MD
Lazcano-Ponce
Eduardo
E
Zielinska-Danch
Wioleta
W
Koszowski
Bartosz
B
Sobczak
Andrzej
A
Havel
Christopher
C
Jacob
Peyton
P
D000328:Adult; D015415:Biomarkers / Q000652:urine*; D002273:Carcinogens / Q000032:analysis / Q000378:metabolism; D002853:Chromatography, Liquid; D003367:Cotinine / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009602:Nitrosamines / Q000378:metabolism / Q000652:urine*; D011725:Pyridines / Q000652:urine*; D012907:Smoking / Q000652:urine*; D053719:Tandem Mass Spectrometry; D014028:Tobacco Smoke Pollution
D015415:Biomarkers; D002273:Carcinogens; D009602:Nitrosamines; D011725:Pyridines; D014028:Tobacco Smoke Pollution; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; C099565:4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol; D003367:Cotinine
Nicotine Tob Res. 2007 Oct;9(10):1021-6
17852765
Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1547-53
17684127
BMJ. 2004 Jul 24;329(7459):200-5
15229131
Tob Control. 2004 Mar;13 Suppl 1:i48-56
14985617
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3421-5
19959691
Am Rev Respir Dis. 1990 Jul;142(1):147-51
2368962
Nicotine Tob Res. 2005 Jun;7(3):443-51
16085512
Epidemiol Rev. 1996;18(2):188-204
9021312
Carcinogenesis. 1990 Oct;11(10):1819-23
2208595
Anal Chem. 2008 Nov 1;80(21):8115-21
18841944
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1184-8
16775179
JAMA. 1998 Jul 8;280(2):152-6
9669788
Environ Sci Technol. 2002 Mar 1;36(5):846-53
11918006
Clin Chem. 1997 Dec;43(12):2281-91
9439445
Chem Res Toxicol. 1998 Jun;11(6):559-603
9625726
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1389-98
20501750
J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210
10413421
Nicotine Tob Res. 2009 Aug;11(8):945-53
19587064
Nicotine Tob Res. 2003 Jun;5(3):323-31
12791527
Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):783-90
9332760
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6576-81
20142504
Handb Exp Pharmacol. 2009;(192):29-60
19184645